ClinicalTrials.gg
RecruitingNCT06134596Updated Nov 18, 2023

Correlation of Clitoral Hood and Labia Minora Measurements and Female Genital Self Image Scale (FGSIS) Scores in Women

An observational study in Genital Diseases, Female and Vulva, sponsored by Bagcilar Training and Research Hospital. Recruiting at 1 site in Turkey. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-18.

Sponsored by Bagcilar Training and Research Hospital · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2023, 2 years 10 months ago, but the record still lists the study as recruiting.
  • Started Nov 2023; still recruiting 3 years later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

To evaluate the relationship between women's labium minora and clitoral hood measurements and Female Genital Self Image Scale (FGSIS) scores.

Read the detailed description

The main purpose of our study is to measure the labium minora and clitoral hood in women who apply to our clinic with gynecological disorders, evaluate them with FGSIS (Female Genital Self Image Scale) scores, and look at the relationship between genital area perception and labium minora and clitoral hood dimensions.

02

Conditions studied

  • Genital Diseases, Female
  • Vulva

Keywords

  • Genital diseases, vulva
03

In context

Genital Diseases, Female

161 studies on the registry are indexed under Genital Diseases, Female; 31 are open to participants now.

This study's planned enrollment of 200 is close to the median of 200 across 37 observational studies indexed under Genital Diseases, Female.

Browse Genital Diseases, Female studies →

Lead sponsor

Bagcilar Training and Research Hospital is the lead sponsor of 55 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Women who apply for outpatient gynecological control, are between the ages of 18-45, are sexually active, do not have additional endocrinological or malignant diseases, and are not pregnant or in menopause.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women who apply for outpatient gynecological control, are between the ages of 18-45, are sexually active, do not have additional endocrinological or malignant diseases, and are not pregnant or in menopause.

Exclusion criteria

Exclusion Criteria:

  • Those who are not sexually active, have varying degrees of pelvic organ prolapse or urinary incontinence, have a , or have an endocrinological disease
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Target follow-up
2 Months
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Correlation of genital measurement with genital perception

    Since the genital aesthetic trend is very popular today, it is important to understand the importance of labia minora and clitoral hood measurements in female genital perception.

    Time frame: 2 months

07

Study locations

1 of 1 sites recruiting
  • Bagcilar Teaching and Research Hospital
    Istanbul, Bagcilar 34200, Turkey
    Recruiting
08

References and documents

Publications

  • Widschwendter A, Riedl D, Freidhager K, Abdel Azim S, Jerabek-Klestil S, D'Costa E, Fessler S, Ciresa-Konig A, Marth C, Bottcher B. Perception of Labial Size and Objective Measurements-Is There a Correlation? A Cross-Sectional Study in a Cohort Not Seeking Labiaplasty. J Sex Med. 2020 Mar;17(3):461-469. doi: 10.1016/j.jsxm.2019.11.272. Epub 2020 Jan 7. PubMed 31918983 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Nov 2023 (actual). Primary completion is estimated for Dec 2023, 1 month after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 11, 2023
First posted
Nov 18, 2023
StartActual
Nov 1, 2023
Primary completionEst.
Dec 31, 2023
CompletionEst.
Mar 1, 2024
Last update
Nov 18, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06134596
Lead sponsor
Bagcilar Training and Research Hospital
Responsible party
Evrim Ebru Kovalak (Medical doctor, Bagcilar Training and Research Hospital) — Principal investigator
First posted
Nov 18, 2023
Start date
Nov 1, 2023
Primary completion
Dec 31, 2023 (estimated)
Completion
Mar 1, 2024 (estimated)
Last update
Nov 18, 2023

Study contacts

Evrim Ebru Kovalak, MD
Contact
evrimebru@yahoo.com
905324628989
Evrim Ebru Kovalak, MD
principal investigator · Bagcilar Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion